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Abstract
Background: Question Prompt Lists (QPLs) have proven very effective in encouraging cancer patients to ask
questions, allowing them to take up a more active role during visits with the oncologist. As no such tool has yet
been validated for Italian-speaking users, we carried out the cross-cultural adaptation and evaluation of an existing
Australian Question Prompt List.
Methods: Cross-cultural adaptation was performed in accordance with the five steps described by Guillemin and
Beaton. Forward and back translations of the original tool were carried out, and the products discussed by an
Expert Committee who agreed on a prefinal version of the Italian QPL, which was submitted to 30 volunteer
patients for evaluation. They rated each question’s adequacy of content, clarity of wording, usefulness, and
generated anxiety, on a 3-point Likert scale. Based on the analysis of patient ratings, the final version of the Italian
QPL was produced.
Results: Few discrepancies between the two back translations and the original version of the instrument were
noted, indicating that the Italian translation (synthesis of the 2 forward translations) was substantially accurate.
Most volunteer patients felt that the questionnaire was adequate, easy to understand and useful. Only a few minor
criticisms were expressed. Certain questions on diagnosis and prognosis generated the highest level of anxiety.
Patient comments and ratings on clarity highlighted the need to clarify common health care terms which are not
widely used by the public (i.e. guideline, multidisciplinary team and clinical trial)
Conclusions: This cross-cultural adaptation has produced an Italian Question Prompt List that is now available for
multi-center international studies and can be safely used with Italian-speaking cancer patients.
Background
Compared to technical aspects of patient care, commu-
nication between the patient and health care profes-
s i o n a l sh a so f t e nb e e nc o n s i d e r e da ni s s u eo fm i n o r
importance, rarely included in medical curricula [1]. In
reality, communication skills are the cornerstone of
comprehensive cancer care. It is increasingly accepted
that good communication is a key to achieving impor-
tant goals of the clinical encounter in oncology: the
quality of the oncologist-patient communication has
been shown to affect crucial aspects including
satisfaction with care, decision making, accrual to clini-
cal trials, pain and other symptoms, and patient distress
[1,2]. Numerous studies have shown that the vast major-
ity of cancer patients wishes to have more information
concerning diagnosis, prognosis and therapeutic options,
as well as a better dialogue with clinicians, even in Italy,
where a generally non-disclosure culture was thought to
predominate [3-6]. Despite these attitudes, these necessi-
ties often remain unheeded. On the one hand, medical
oncologists and healthcare staff generally underestimate
this need, find it difficult to reveal prognostic uncertain-
ties, and underestimate patient knowledge of medical
terms [7-9]; furthermore, particularly in countries with a
tradition of non-disclosure like Italy, clinicians tend to
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want and need [10,11]. In Italy this situation has led to
the establishment of information campaigns devoted to
alternative forms of therapy that have caused serious
harm to patients and public health care services as a
whole [10].
On the other hand, patients themselves are often
reluctant or unable to initiate conversations on issues of
concern, for various reasons: they are afraid they might
be annoying or taking up too much of a busy doctor’s
time, they fear their illness and the answers they may
receive, they are afraid of sounding ignorant, or are con-
fident that the physician will tell them all they need to
know [1,12]. Based on these considerations, tools aiming
to favor patient-physician communication and to encou-
rage patient participation in the medical consultation
and decision-making process are urgently needed.
Question Prompt Lists (QPLs), consisting of a struc-
tured list of questions that patients may wish to ask
their physician, have been shown to facilitate communi-
cation between patients and physicians about illness and
treatment, as measured objectively through the number
of patient questions asked or subjectively through
patient self-report [13]. QPLs are generally given
patients before the consultation, leaving them enough
time to read through them and mark the questions that
they would like to ask.
To our knowledge, no research on the use of QPLs in
Italy has been reported. Given the positive results
obtained with this tool in English-speaking countries, it
is essential that this tool be offered to cancer patients
from other countries and cultures as well.
This study was sponsored by the Italian Ministry of
Health and by the Lombardy Region, as part of a
broader implementation project aiming to introduce in
Italian cancer centers a series of evidence-based activ-
ities for the improvement of the humanization of can-
cer care (HUCARE project). Such activities include
communication courses for medical oncologists and
nurses, the construction of a PIS (Point of Information
and Support) inside the hospital ward [14], the assign-
ment of a referring nurse to all new patients and the
measuring of psychological distress for all cancer
patients. The adoption of a QPL is one of the activities
of the HUCARE project for the improvement of doc-
tor-patient communication, which obtained approval
from the Ethics Committee of Cremona. Instead of
devising and validating our own Question Prompt List,
given the availability of already validated, widely used
QPLs in the English language, we decided to carry out
the cross-cultural adaptation of one of these existing
instruments, and to test it on a selected group of Ita-
lian cancer patients.
Methods
The Instrument
Literature analysis was carried out to identify reports of
Question Prompt List use in oncology. We only found
experiences relating to English-speaking countries, with
no report of cross-cultural adaptation in any language.
A metanalysis of such studies, conducted at the Medical
Psychology Research Unit (MPRU) at the University of
Sydney, Australia, shows that more than half of such
studies were carried out at the MPRU itself [13]. Given
the extensive research on the subject by this Australian
group, we opted to employ the instrument devised at
the MPRU, presented in the above mentioned metanaly-
sis by Dimoska et al, dedicated to the communication
with the medical or radiation oncologist, available for
download from the MPRU website [15].
The booklet contains 49 questions, subdivided into
eleven domains: “how and when to ask questions”,
“diagnosis”, “tests”, “prognosis”, “optimal care”, “the
multidisciplinary team”, “treatment information and
options”, “clinical trials”, “preparing for treatment”,
“costs”, “support information”.
Permission to translate and adapt the tool was
obtained from the developers.
Cross-cultural adaptation
Translating a tool into another language is not enough
to ensure validity. Cross-cultural adaptation is a com-
plex, well-defined process, aiming to ensure that the
translated version is culturally sensitive, as large varia-
tions exist between cultures in attitudes toward disease,
participation in decision-making, and in discussing ill-
ness [13]. Guidelines have been developed delineating
the necessary steps for this task, however no such guide-
line exists on the cross-cultural adaptation of a QPL
[16]. We thus followed the five steps described by Guil-
lemin et al [17] and Beaton et al [18], intended for ques-
tionnaires of self-report health status measures, as
follows.
Stage I - initial translation: two certified translators
with Italian as their mother tongue (Translator1 and
Translator2) independently translated the tool into Ita-
lian producing two forward translations defined as T1
and T2. As recommended by Beaton et al. [18], the
translators had different backgrounds: Translator1, one
of the co-authors of this paper, is employed at the Uni-
versity Hospital of Parma, and is a member of the
HUCARE Project’s Coordination group, thus fully aware
of the study’s rationale and aims, while Translator2 is a
certified translator with no specific background in
oncology, and was not informed of the aims of the
study nor of the existence of the HUCARE project.
Stage II - synthesis: The two translators met to discuss
their work, and agreed on a common Italian version,
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crepancies between the translations and difficulties
encountered.
Stage III - back translation: two English native speak-
ing certified translators translated T12 into English.
Both had no specific background in oncology, nor were
t h e yi n f o r m e do ft h ea i m so ft h es t u d ya n do ft h ee x i s -
tence of the Hucare Project.
Stage IV - Expert Committee - a Committee was set
up with the aim to examine all translated versions
against the original tool, and produce the so-called
“prefinal version” of the QPL. The composition of the
Committee, in strict accordance with the requirements
of Beaton et al [18] included the following figures: the
four translators, one oncologist - also the project man-
ager -, one methodologist-biostatistician, one psycholo-
gist, one sociologist, one linguist. Each question was
d i s c u s s e da n de v a l u a t e df r o ma l lt h ev i e w p o i n t so ft h e
different professionals in the Committee, particularly
concerning semantic equivalence, idiomatic equivalence,
experiential equivalence and contextual equivalence.
Stage V - test of the prefinal version: the Italian ver-
sion agreed on by the Committee was shared with a
group of oncologists, the Directors of 7 of the cancer
centers participating in the HUCARE project, to obtain
endorsement, and was subsequently submitted to a sam-
ple of cancer survivors (former patients or currently in
follow-up), recruited from two voluntary patient organi-
zations based in the Northern Italian towns of Reggio-
Emilia and Cremona. A psychologist presented the QPL
and its objectives to the patients, and requested them to
rate each question’s adequacy of content (if the wording
and content of the question was adequate to the con-
text), clarity of wording, usefulness, and the level of
anxiety it generated, using a 3-point Likert scale, as well
as to provide any comments or suggestions.
In line with the recommendations of the International
Society for Pharmacoeconomics and Outcomes Research
(ISPOR) Task Force for Translation and Cultural Adap-
tation [16], the prefinal translation was reviewed in the
light of the findings of Stage V, proofread for any spel-
ling or grammatical errors, and finalized with the
approval of the project manager.
Statistical analysis
Descriptive analysis of patient feedback (stage V) was
carried out, considering the scores attributed to each
item of the QPL. To facilitate comprehension, and high-
light differences, frequencies were displayed by means of
histograms (Figures 1, 2, 3, and 4). 50% cut offs were
considered as significant for analysis by the Committee.
Results
A total of 49 questions underwent cross-cultural adapta-
tion (see additional file 1: QPL final version following
patient evaluation). All five stages were carried out in
strict adherence to the indications of the literature [18].
Concerning Stage II and III of the process, few discre-
pancies between the two back translations and the origi-
nal version of the instrument were noted, indicating
t h a tT 1 2( s y n t h e s i so ft h e2f o r w a r dt r a n s l a t i o n s )w a s
substantially accurate.
In stage IV, the directness of the language used in the
Australian QPL, typical of English-speaking cultures,
proved to be the major source of debate among the
Committee. In some cases, items were slightly rephrased
to make them less direct, still ensuring to maintain the
original meaning. A faithful translation of the expression
“so you have cancer...” was unanimously considered
unacceptable for Italian users, and therefore was
removed from the Italian version. The Committee also
agreed not to use the Italian counterpart for “cancer”,
which carries a strong connotation of malignancy,
although some Italian experts now feel the word should
be used with patients. The milder term “tumor” was
preferred, or in some cases, “cancer” was translated with
the phrase “my illness”,a st h i se x p r e s s i o ni so f t e nu s e d
by Italian-speaking oncology patients referring to their
disease. In other instances, terms judged to be particu-
larly harsh were maintained, as not to impact on the
meaning, e.g. the expression “cancer survivor”,w h i c h
may sound somewhat disturbing to some Italian
patients.
Other points of discussion within the Committee con-
cerned the choice of technical vs. more colloquial terms.
Generally, it was decided to keep the language informal
and simple, following the English version, although in
some cases the wording was slightly modified to better
suit the Italian style.
A few idiomatic expressions proved problematic: in
particular, the heading “Optimal care” was challenging
for the forward translators, consequently causing the
back translations of the phrase to be incongruent with
the original version. The Committee finally agreed on a
somewhat free translation of the heading: “Ensuring the
best possible care”.
The original QPL contained a few English words that
are also used in Italian “checklist, follow-up, team”.T h e
Committee however chose to replace them with Italian
terms, as they may not be known by all possible users.
From a grammatical point of view, the Committee
took care to leave open questions open, although in
some instances a closed question would have sounded
better to Italian ears.
30 patients participated in the evaluation of the items,
completing Stage V of the cross-cultural adaptation pro-
cess. 60% of the sample was female, median age was 60
years; level of education was as follows: 13% primary
school, 20% secondary school, 60% highschool, and 7%
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cerning the four dimensions of adequacy of content,
clarity of wording, usefulness, and level of anxiety,
expressed on a 3-point Likert scale, are depicted in Fig-
ures 1, 2, 3, and 4, respectively. For each dimension,
three histograms were constructed, relative to the three
scores: low, medium, and high. In each histogram, the
X-axis depicts the 49 questions, and the Y-axis shows
the frequency of the score expressed as percentages. To
facilitate interpretation, the eleven domains, into which
the questions were subdivided in the booklet, are
highlighted.
Most questions received high scores (> 90%) for ade-
quacy of content and clarity of wording (Figures 1 and
2). Ratings for clarity were slightly lower (< 70%) only
for questions 19, 21, 22, 36, and 37 (see additional file 1:
QPL final version following patient evaluation). Con-
cerning usefulness, results were less uniform (Figure 3).
Scores were particularly high for most questions in the
“prognosis”, “treatment information and options” and
“preparing for treatment” domains. A few items received
low scores: questions 20, 21, 22, 25, 35 (see additional
file 1: QPL final version following patient evaluation).
What these questions have in common is that they
investigate factors external to the patient-physician rela-
tionship and not referring to the patient condition (sec-
ond opinion, the multidisciplinary team, public vs.
private institutions).
The level of anxiety generated by questions was
judged low for most items (Figure 4). Only for the
domains of diagnosis and prognosis, most questions
received high scores (> 50% of patients).
The evaluation sheet also provided space next to each
item where respondents could leave comments, which
would be useful to identify frequent problems or obser-
vations. Comments were provided by 9 out of 30 sub-
jects, and were most frequent in the “Optimal Care” and
“The Multidisciplinary Team” domains. In particular, 5
patients indicated that they did not know the meaning
of the terms “guidelines” and “multidisciplinary team”.
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Figure 1 Adequacy. Patient ratings on adequacy of content of each question, expressed on a 3-point Likert scale.
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decided to revise the prefinal version, rephrasing ques-
tions 19, 21, 22, 36 and 37 in order to improve clarity.
Questions 20 and 25, regarding seeking a second opinion
and the relationship to multiple members of a team, were
not removed, despite their low usefulness scores, as the
group considered these to be crucial issues requiring spe-
cial attention in the Italian culture. Similarly, question 35,
concerning care in the public vs. private sectors, was not
deleted despite its low usefulness scores. In fact, although
differences between public and private institutions are not
so evident in Italy, the question would be relevant to Italian
speaking patients living in other countries.
Discussion
The evidence supporting the positive effects of QPLs in
oncology obtained in English-speaking countries call for
an extension of their availability to other linguistic
groups. To our knowledge, this is the first report of the
cross-cultural adaptation of a QPL for cancer patients.
By strictly following the indications in the literature
for cross-cultural adaptation of an instrument, we have
ensured that the translated questionnaire is suitable for
use with Italian-speaking cancer patients.
The multidisciplinary nature of the Expert Committee
was crucial in reaching an appropriate version, examin-
ing the work from different points of view: oncologist,
methodologist, translator, linguist, psychologist, sociolo-
gist. The major obstacles encountered by the Committee
seemed to lie in the directness of the language used in
the Australian QPLs, which required some degree of
“mitigation” of the language, obviously without modify-
ing the meaning of the items.
Finally, judgments expressed by patients on each ques-
tion in stage V of the process, provided the indispensable
patient perspective to ensure that the tool may be used
safely with newly diagnosed cancer patients, who are cer-
tainly under considerable stress and much more vulner-
able. Patient feedback provided an insight into the Italian
culture, confirming that the somewhat paternalistic
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Figure 2 Clarity. Patient ratings on clarity of wording of each question, expressed on a 3-point Likert scale.
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Page 5 of 8nature of the patient-physician relationship is still pre-
sent. The fact that many respondents did not consider
useful items relating to seeking a second opinion and
handling instructions from health care professionals
other than their oncologist may suggest a lack of patient
empowerment, and a tendency to entrust care decisions
to the doctor. The Committee decided to maintain these
items despite their low usefulness ratings, since the aim
of the QPL is actually to favor patient empowerment and
fulfill patient information needs, which may not even be
always realized fully by the patients themselves. The lit-
erature supports this view: in a 1999 survey conducted
on 1120 Italian cancer patients, more than half of respon-
dents (53%) declared that they would base their choice of
treatment on their doctor’s recommendations, and only
32% on scientific evidence [3].
The feedback obtained by the patients in our survey is
in line with findings of research on QPL use. In particu-
lar, English QPLs had been shown to increase likelihood
that a patient would ask at least 1 question about prog-
nosis [19], a topic that is typically avoided by both can-
cer patients and physicians during the consultation [20].
In fact, the “prognosis” domain was ranked among the
first for usefulness by our sample.
Scores for anxiety generated by questions were high
for many items in the “diagnosis” and “prognosis”
domains. This was expected, considering the impact of a
cancer diagnosis and its prognosis on a person’sl i f e .
However, there is evidence that lack of information can
actually increase anxiety and uncertainty, while good
communication was reported to be associated with bet-
ter emotional adjustment [11]; findings which are part
of the rationale for QPL introduction in oncology set-
tings. Contrary to what feared by some clinicians, the
review by Dimoska et al reports that no study detected
a negative effect of the QPL on psychological outcomes,
and that 2 papers demonstrated anxiety actually
decreased after the patient received the QPL.
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Figure 3 Usefulness. Patient ratings on usefulness of each question, expressed on a 3-point Likert scale.
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Page 6 of 8This initiative is part of a large, multicenter, nation-
wide implementation study financed by the Italian Min-
istry of Health, the HUCARE Project, aiming to
introduce evidence-based interventions to cancer centers
with the objective of “humanizing” the care of cancer
patients by improving patient information, patient-physi-
cian communication, as well as detection and fulfillment
of patient psychosocial needs. The introduction of a
QPL in all participating centers is one of the key inter-
ventions foreseen in the Hucare protocol, which con-
tains specific indications on its use, in strict accordance
with published evidence. As indicated by the Australian
research group [13], the QPL will be given to patients
by their oncologist, who will explain to them its content
and purpose, reassuring them that asking questions is
their right and reiterating his/her willingness to answer
any concern, no matter how trivial it may seem to the
patient. The Hucare project also includes specific train-
ing for physicians on patient-clinician communication,
where all aspects of QPL use are discussed.
Conclusions
Enhancing communication between patients and physi-
cians is a key aspect of cancer care. The process of
cross-cultural adaptation we followed has produced a
Question Prompt List that is now available for multi-
center international studies and can be safely used with
Italian-speaking cancer patients. All self-administered
instruments aimed at the improvement of care (health
assessment questionnaires, questionnaires on patient
needs, depression and anxiety scales, etc.) should be
translated and validated in order to be used by all
patients, regardless of their culture and language.
Additional file 1: QPL final version following patient evaluation.T h e
49 original questions and the Italian final version, grouped into the 11
domains.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-6963-10-
16-S1.DOC]
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Figure 4 Anxiety. Patient ratings on anxiety generated by each question, expressed on a 3-point Likert scale.
Caminiti et al. BMC Health Services Research 2010, 10:16
http://www.biomedcentral.com/1472-6963/10/16
Page 7 of 8Acknowledgements
We thank the members of the Expert Committee - professional translators
Enrica Bondavalli, Gabriella Grasselli and Stevie Johnson, and linguist Renata
Todeschini - for their essential contribution to the study. We are extremely
grateful to the authors of the Australian Question Prompt List, and to Dr.
Lesley Fallowfield, for their precious support and suggestions. Our thanks
also go to Jessica Saleri, for her assistance with secretarial work. We are
grateful to the Italian Ministry of Health for sponsoring this study in the
framework of the Hucare (Humanization in Cancer Care) project.
Author details
1Research Innovation Unit, University Hospital of Parma, Italy.
2Division of
Medical Oncology, Istituti Ospitalieri, Cremona, Italy.
3Unit of Oncological
Psychology, Istituto Nazionale Tumori, Aviano, Italy.
Authors’ contributions
CC conceived of the study, designed the methodology, performed data
interpretation and supervised the entire process, up to the drafting of the
manuscript. FD was one of the two forward translators, performed literature
review and contributed to the drafting of the manuscript. SF was in charge
of stage V of the process, she recruited patients and assisted them in the
completion of the self-administered questionnaire. BM carried out data
analysis and developed the graphs used for result interpretation. MAA and
MO contributed to the work of the Expert Committee. RP is the coordinator
of the Hucare project and devised all interventions foreseen in the Hucare
protocol, including QPL introduction; he was responsible for the entire
process: selection of all figures involved, coordination of meetings, and
decision-making based on the study results.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 31 August 2009
Accepted: 15 January 2010 Published: 15 January 2010
References
1. Fallowfield L, Jenkins V: Effective communication skills are the key to
good cancer care. Eur J Cancer 1999, 35:1592-1597.
2. Baile WF, Aaron J: Patient-physician communication in oncology: past,
present, and future. Curr Opin Oncol 2005, 17:331-335.
3. Passalacqua R, Campione F, Caminiti C, Salvagni S, Barilli A, Bella M, Barni S,
Barsanti G, Caffo O, Carlini P, Cinquemani G, Di Costanzo F, Giustini L,
Labianca R, Mazzei A, Olmeo N, Paccagnella A, Toscano L, Cocconi G:
Patients’ opinions, feelings, and attitudes after a campaign to promote
the Di Bella therapy. Lancet 1999, 353:1310-1314.
4. Jenkins V, Fallowfield L, Saul J: Information needs of patients with cancer:
results from a large study in UK cancer centres. Br J Cancer 2001, 84:48-
51.
5. Yun YH, Lee CG, Kim SY, Lee SW, Heo DS, Kim JS, Lee KS, Hong YS, Lee JS,
You CH: The attitudes of cancer patients and their families toward the
disclosure of terminal illness. J Clin Oncol 2004, 22:307-314.
6. Piredda M, Rocci L, Gualandi R, Petitti T, Vincenzi B, De Marinis MG: Survey
on learning needs and preferred sources of information to meet these
needs in Italian oncology patients receiving chemotherapy. Eur J Oncol
Nurs 2008, 12:120-126.
7. Chapman K, Abraham C, Jenkins V, Fallowfield L: Lay understanding of
terms used in cancer consultations. Psychooncology 2003, 12:557-566.
8. Mystakidou K, Parpa E, Tsilila E, Katsouda E, Vlahos L: Cancer information
disclosure in different cultural contexts. Support Care Cancer 2004, 12:147-
154.
9. Hagerty RG, Butow PN, Ellis PM, Dimitry S, Tattersall MH: Communicating
prognosis in cancer care: a systematic review of the literature. Ann Oncol
2005, 16:1005-1053.
10. Passalacqua R, Caminiti C, Salvagni S, Barni S, Beretta GD, Carlini P, Contu A,
Di Costanzo F, Toscano L, Campione F: Effects of media information on
cancer patients’ opinions, feelings, decision-making process and
physician-patient communication. Cancer 2004, 100:1077-1084.
11. Costantini M, Morasso G, Montella M, Borgia P, Cecioni R, Beccaro M,
Sguazzotti E, Bruzzi P, ISDOC Study Group: Diagnosis and prognosis
disclosure among cancer patients. Results from an Italian mortality
follow-back survey. Ann Oncol 2006, 17:853-859.
12. Jefford M, Tattersall MH: Informing and involving cancer patients in their
own care. Lancet Oncol 2002, 3:629-637.
13. Dimoska A, Tattersall MH, Butow PN, Shepherd H, Kinnersley P: Can a
“prompt list” empower cancer patients to ask relevant questions?.
Cancer 2008, 113:225-237.
14. Passalacqua R, Caminiti C, Campione F, Diodati F, Todeschini R, Bisagni G,
Labianca R, Dalla Chiesa M, Bracci R, Aragona M, Artioli F, Cavanna L,
Masina A, De Falco F, Marzocchini B, Iacono C, Contu A, Di Costanzo F,
Bertetto O, Annunziata MA: Prospective, multicenter, randomized trial of
a new organizational modality for providing information and support to
cancer patients. J Clin Oncol 2009, 27:1794-1799.
15. MPRU - Medical Psychology Research Unit. http://www.psych.usyd.edu.au/
mpru/communication_tools.html, (accessed August 2009).
16. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A,
Erikson P, ISPOR Task Force for Translation and Cultural Adaptation:
Principles of Good Practice for the Translation and Cultural Adaptation
Process for Patient-Reported Outcomes (PRO) Measures: report of the
ISPOR Task Force for Translation and Cultural Adaptation. Value Health
2005, 8:94-104.
17. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of health-
related quality of life measures: literature review and proposed
guidelines. J Clin Epidemiol 1993, 46:1417-1432.
18. Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the
process of cross-cultural adaptation of self-report measures. Spine (Phila
Pa 1976) 2000, 25:3186-3191.
19. Brown R, Butow P, Dunn S, Tattersall M: Promoting patient participation
and shortening cancer consultations: a randomised trial. Br J Cancer
2001, 85:1273-1282.
20. Tamburini M, Gangeri L, Brunelli C, Boeri P, Borreani C, Bosisio M,
Karmann CF, Greco M, Miccinesi G, Murru L, Trimigno P: Cancer patients’
needs during hospitalisation: a quantitative and qualitative study. BMC
Cancer 2003, 3:12.
Pre-publication history
The pre-publication history for this paper can be accessed here:http://www.
biomedcentral.com/1472-6963/10/16/prepub
doi:10.1186/1472-6963-10-16
Cite this article as: Caminiti et al.: Cross-cultural adaptation and
patients’ judgments of a Question Prompt List for Italian-speaking
cancer patients. BMC Health Services Research 2010 10:16.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Caminiti et al. BMC Health Services Research 2010, 10:16
http://www.biomedcentral.com/1472-6963/10/16
Page 8 of 8